Forecast: Capital Health Expenditure in China

The forecasted capital health expenditure in China shows a steady increase from 0.82% of GDP in 2024 to 0.91% of GDP by 2028. This signifies a consistent year-on-year growth, with the expenditure rising by approximately 2.4%-3.4% annually. This upward trend underscores the increasing prioritization of healthcare investments in China’s economic planning.

Over the last two years, the growth rate has shown a stable increment, reflecting the country's commitment to enhancing healthcare infrastructure. The compound annual growth rate (CAGR) over the next five years is projected to be around 2.6% per annum.

Future trends to watch for include the impact of aging demographics on healthcare demands, government policies promoting healthcare advancements, and potential private sector investment in health technology and services. Monitoring these elements will be essential to understanding the dynamics of capital health expenditure in China moving forward.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease